F
Femicare vzw | Tienen, BE
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Elinzanetant
BAY3427080
Domiphen Bromide
Vilaprisan
Miconazole Nitrate
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
Researchers are looking for a better way to treat women with, or at high risk for developing hormone-receptor positive breast cancer, who have vasomo...
Active, not recruiting
Hot Flashes
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
Drug: Placebo
Drug: Elinzanetant (BAY3427080)
The purpose of this study is to evaluate the efficacy, immunogenicity and safety of the 9-valent human papillomavirus (9vHPV) vaccine in men 20 to 45...
Active, not recruiting
Papillomavirus Infections
Biological: 9vHPV Vaccine
Other: Placebo (Saline for Injection)
Trial sponsors
A
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems